Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 10 months
- Director since
- 2026
10 months of board service in total across 1 board, counting each seat separately. Longest: Indivior Pharmaceuticals Inc., 10 months.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Indivior Pharmaceuticals Inc. May 13, 202699.9%
-
Indivior Pharmaceuticals Inc. May 8, 202599.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +6,518 | — | — |
| Jan 26, 2026 | Indivior Pharmaceuticals Inc. | Grant or award | +3,722 | — | — |
| Jan 5, 2026 | Indivior Pharmaceuticals Inc. | Open-market purchase | +775 | $35.39 | $27,427 |
Questions about Mark Stejbach
What boards is Mark Stejbach on?
Mark Stejbach sits on the board of Indivior Pharmaceuticals Inc.
How long has Mark Stejbach served on boards?
Our records show at least 10 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.